Although neutralizing antibodies to AAV exist, it was shown that second administration of AAV2 vector expressing RPE65 gene into the subretinal space in individuals with inherited retinal dystrophy to the second eye after previous exposure to AAV2 was safe and effective [57]. This evidence concerns the gene RPE65 and Retinal dystrophy.